He, Qingling
Hu, Jianyang
Ngo, Fung-Yin
Zhang, Huiqi
He, Lin
Huang, Hao
Wu, Tan
Pan, Yilin
Yang, Zihan
Jiang, Yuanyuan
Cho, William C.
Cheuk, Wah
Tse, Gary M.
Tsang, Julia Y.
Yang, Mengsu
Zhang, Liang
Wang, Xin
Lo, Pui-Chi
Lau, C. Geoffrey
Chin, Y. Rebecca https://orcid.org/0000-0001-8976-3466
Funding for this research was provided by:
Research Grants Council, University Grants Committee (11103719, 11102322, 14104223, R1020-18, R1020-18)
National Natural Science Foundation of China (81972781, 82273470)
City University of Hong Kong (7005517, 7005739, 7005872, 9609316, 7020033, 9683001, 9610559)
Article History
Received: 23 May 2024
Accepted: 1 February 2025
First Online: 17 February 2025
Declarations
:
: The procedures involved in clinical breast cancer samples were approved by the Human Subjects Ethics Committees at City University of Hong Kong and conformed to government regulations for research involving human participants. Informed consent was obtained from the breast cancer patients. All procedures of animal studies followed the protocol approved by the Animal Ethics Committees at City University of Hong Kong and conformed to government guidelines for the care and maintenance of laboratory animals.
: Not applicable.
: The authors declare no potential conflicts of interest.